1 |
Liu J, Zong C, Yu X, Ding Y, Chang B, Wang R, Sang L. Alanyl-Glutamine (Ala-Gln) Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by Regulating the Gut Microbiota, PI3K-Akt/NF-κB/STAT3 Signaling, and Associated Pulmonary Injury. ACS Infect Dis 2023. [PMID: 36917734 DOI: 10.1021/acsinfecdis.3c00014] [Reference Citation Analysis]
|
2 |
Laurindo LF, de Maio MC, Minniti G, de Góes Corrêa N, Barbalho SM, Quesada K, Guiguer EL, Sloan KP, Detregiachi CRP, Araújo AC, de Alvares Goulart R. Effects of Medicinal Plants and Phytochemicals in Nrf2 Pathways during Inflammatory Bowel Diseases and Related Colorectal Cancer: A Comprehensive Review. Metabolites 2023;13. [PMID: 36837862 DOI: 10.3390/metabo13020243] [Reference Citation Analysis]
|
3 |
Wu F, Liu Y, Hu S, Lu C. Ribosomal protein L31 (RPL31) inhibits the proliferation and migration of gastric cancer cells. Heliyon 2023;9:e13076. [PMID: 36816257 DOI: 10.1016/j.heliyon.2023.e13076] [Reference Citation Analysis]
|
4 |
Xiu M, Wang Y, Yang D, Zhang X, Dai Y, Liu Y, Lin X, Li B, He J. Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease. Front Pharmacol 2022;13:1072715. [PMID: 36545307 DOI: 10.3389/fphar.2022.1072715] [Reference Citation Analysis]
|
5 |
Roy S, Dhaneshwar S, Mahmood T, Kumar S, Saxena SK. Pre-clinical Investigation of Protective Effect of Nutraceutical D-Glucosamine on TNBS-induced Colitis. Immunopharmacol Immunotoxicol 2022;:1-33. [PMID: 36154797 DOI: 10.1080/08923973.2022.2128370] [Reference Citation Analysis]
|
6 |
Yang S, Li X, Xiu M, Dai Y, Wan S, Shi Y, Liu Y, He J. Flos puerariae ameliorates the intestinal inflammation of Drosophila via modulating the Nrf2/Keap1, JAK-STAT and Wnt signaling. Front Pharmacol 2022;13:893758. [DOI: 10.3389/fphar.2022.893758] [Reference Citation Analysis]
|
7 |
Wang M, Huang X, Kang Z, Huang J, Wei S, Zhao H, Zhong Y, Liu D. Mechanism of Sishen-Pill-Regulated Special Memory T and mTfh Cell via Involving JAK/STAT5 Pathway in Colitis Mice. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-12. [DOI: 10.1155/2022/6446674] [Reference Citation Analysis]
|